首页> 外国专利> Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients

Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients

机译:通过非组胺能机制介导的糖尿病性瘙痒病的治疗方法

摘要

Described herein are methods of treating a mammal in need of treatment for non-histaminic pruritus by administering to the mammal in need thereof a therapeutically effective amount of RS-norketotifen or a pharmaceutically acceptable salt thereof, thereby reducing the desire to scratch in the mammal. Non-histaminergic types of pruritus are resistant to treatment with selective histamine H-1-, H-2- and H-4-receptor inhibitors. In certain aspects, the non-histaminergic pruritus is associated with diabetes.
机译:本文描述了通过向需要治疗的哺乳动物施用治疗有效量的RS-去甲肾上腺素或其药学上可接受的盐,从而减少在哺乳动物中抓挠的需要,来治疗需要治疗非组胺性瘙痒的哺乳动物的方法。非组织胺能性瘙痒症对选择性组胺H-1-,H-2-和H-4-受体抑制剂的治疗有抵抗力。在某些方面,非组织胺能性瘙痒症与糖尿病有关。

著录项

  • 公开/公告号US9439895B2

    专利类型

  • 公开/公告日2016-09-13

    原文格式PDF

  • 申请/专利权人 BRIDGE PHARMA INC.;

    申请/专利号US201615134807

  • 发明设计人 VINCENT B. CIOFALO;A.K. GUNNAR ABERG;

    申请日2016-04-21

  • 分类号A01N43/40;A61K31/445;A61K31/4535;A61K9/00;

  • 国家 US

  • 入库时间 2022-08-21 14:33:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号